Clinical Trials Logo

Retinal Disease clinical trials

View clinical trials related to Retinal Disease.

Filter by:

NCT ID: NCT05836194 Recruiting - Diabetes Mellitus Clinical Trials

Evaluation of Diabetic Retinopathy Using Ultra-Widefield Fundus Images Compared With Two-Field Fundus Images

Start date: February 1, 2023
Phase:
Study type: Observational

This study aims to compare the accuracy of evaluating diabetic retinopathy using ultra-widefield fundus images versus two-field fundus images. The hypothesis is that screening and grading diabetic retinopathy based on ultra-widefield fundus images may yield higher accuracy compared to the use of two-field fundus images.

NCT ID: NCT05797896 Recruiting - Clinical trials for Macular Degeneration

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

i-GAIN
Start date: February 7, 2023
Phase:
Study type: Observational

An observational study to investigate the natural history and evaluate biomarkers of participants with geographic atrophy secondary to age-related macular degeneration

NCT ID: NCT05750589 Recruiting - Retinal Disease Clinical Trials

Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

COMFORT
Start date: February 22, 2023
Phase: Phase 3
Study type: Interventional

This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections.

NCT ID: NCT05747430 Recruiting - Retinal Disease Clinical Trials

SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

RELIEF
Start date: February 22, 2023
Phase: Phase 2
Study type: Interventional

This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 15 centers in the United States (US).

NCT ID: NCT05724641 Recruiting - Retinal Diseases Clinical Trials

Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application

PerfRet
Start date: January 10, 2023
Phase: N/A
Study type: Interventional

The MRI perfusion imaging using arterial spin labeling (ASL)'s non-invasive technique (i.e. without injection of contrast medium) allows, thanks to recent technological improvement of the spatial resolution, measuring several perfusion parameter of the retinal tissue such as the regional Blood Flow (rBF) or the cerebral blood flow (cBF) expressed in ml/100g/min. Reliable application of ASL thus requires the precision and specificity of the MRI protocol to be tested.

NCT ID: NCT05699096 Recruiting - Retinal Disease Clinical Trials

Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly

Start date: July 1, 2023
Phase:
Study type: Observational

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

NCT ID: NCT05623293 Recruiting - Carotid Stenosis Clinical Trials

Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis

Start date: January 1, 2022
Phase:
Study type: Observational

The retinal vessels have been shown to reflect vascular changes inherent to systemic pathologies, even when no ocular disease is identified. As such, the eye's vasculature is ableto serve as a window to the vascular health of the human body and a means of assessing systemic endothelial function. Optical coherence tomography angiography (OCTA) employs optical means to image all the retinal vascular layers and the choroid, providing an extremely detailed image of the microvascular network in a fast, reproducible and totally non-invasive way. As such, it is currently the best non-invasive way of having an image of human capillaries. Recently, OCTA has been used to study the retinal vessels' structure and function in several cardiovascular diseases. As an example of its predictive potential, reduced retinal microvascular density has been associated with the cardiovascular risk profile in patients admitted to the hospital for an acute coronary syndrome. Recent studies have also shown the retinal microvasculature density to be reduced in patients with carotid artery disease (CAD), namely carotid stenosis, and that endarterectomy increases retinal flow and vessel density.

NCT ID: NCT05447845 Recruiting - Cataract Clinical Trials

Rapid Computerized Visual Acuity Test

Start date: January 1, 2019
Phase:
Study type: Observational

A novel computerized visual acuity test was developed and tested on both healthy persons and patients with ocular conditions. Visual acuity outcomes of the computerized test will be compared to the Early Treatment Diabetic Retinopathy Study (ETDRS) in measures of reproducibility, accuracy and numbers of questions.

NCT ID: NCT05334875 Recruiting - Retinal Disease Clinical Trials

Repeatability of Electroretinogram and Visual Evoked Potential

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

To assess repeatability of electroretinogram and visual evoked potential in clinical practice

NCT ID: NCT05323032 Recruiting - Retinal Disease Clinical Trials

Multifocal Electroretinogram in Normal Egyptian Population

Start date: March 22, 2022
Phase: N/A
Study type: Interventional

Studying normal subjects to create unique normal database for multifocal electroretinogram (mf-ERG) in specific population.